Table 1

Demographic and clinical characteristics on admission

VariablePatients with complete data
(n=224)
Patients with missing data (n=14)Difference between median values
Age, median (IQR), years52 (38–60)54.5 (43–61)p=0.29
Gender,
 Male, n (%)138 (61.6%)7 (50%)p=0.30
 Female, n (%)86 (38.4%)7 (50%)
Affected limb*
 Left, n (%)117 (51.3%)8 (57.1%)p=0.39
 Right, n (%)107 (48.7%)6 (42.9%)
 Non dominant110 (49.1%)7 (50.0%)p=0.87
 Dominant114 (50.9%)7 (50.0%)
Median time since stroke
Months (IQR)
18 (12–51)16 (12–22)p=0.29
Modified Rankin scale, n (%)
 Median (IQR)2 (2–3)2 (2–2.75)p=0.32
  No significant disability20 (9.9%)2 (14.3%)
  Slight disability106 (47.4%)8 (57.1%)
  Moderate disability95 (42.4%)4 (28.6%)
  Moderately severe3 (1.3)0 (0%)
The Barthel Index, median (IQR), Max=2019 (17–19)19 (18–20)p=0.12
The Neurological Fatigue Index, median (IQR), Max=6235 (25–42)33 (23–38)p=0.34
Hospital Anxiety and Depression Scale, median (IQR), Max=3412 (8–16)13 (8.5–18)p=0.64
Sensory loss, n, %
 0=Severe13 (5.8%)2 (14.3%)p=0.36
 1=Mild111 (49.6%)7 (50%)
 2=Normal100 (44.6%)5 (35.7%)
Modified Fugl-Meyer
(upper limb), median (IQR) Max=54
26 (16–37)27.5 (19–34)p=0.92
Action Research Arm Test, median (IQR), Max=5718 (7–33)15 (9.5–23)p=0.92
Chedoke Arm and Hand Activity Inventory, median (IQR),
Max=91
40 (28–55)33.5 (27–40)p=0.37
ArmA-A,
median (IQR), Max=28
8 (5–12)†8 (6–12)‡p=0.55
ArmA-B,
median (IQR), Max=52
38 (24–46)†36 (29–41)‡p=0.65
  • Difference in medians tested with Wilcoxon signed-rank test. Difference in proportions was tested with χ2 test.

  • *202 (90.2%) patients were right-handed, 22 (9.8%) patients were left-handed.

  • †195 patients out of 224 had ArmA-A and ArmA-B measured on admission.

  • ‡11 patients out of 14 had ArmA-A and ArmA-B measured on admission. *202 (90.2%) patients were right-handed, 22 (9.8%) patients were left-handed.

  • ArmA-A, Arm Activity Measure A; ArmA-B, Arm Activity Measure B.